HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Marampon Selected Research

palomid 529

6/2014Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
8/2011The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Marampon Research Topics

Disease

47Neoplasms (Cancer)
02/2022 - 08/2006
21Prostatic Neoplasms (Prostate Cancer)
01/2021 - 08/2010
14Glioblastoma (Glioblastoma Multiforme)
01/2022 - 06/2014
11Rhabdomyosarcoma
10/2021 - 12/2005
8Embryonal Rhabdomyosarcoma
01/2022 - 12/2005
4Glioma (Gliomas)
01/2022 - 05/2017
3Parkinson Disease (Parkinson's Disease)
06/2022 - 01/2019
3Inflammation (Inflammations)
05/2021 - 05/2014
3Sarcoma (Soft Tissue Sarcoma)
01/2020 - 01/2019
3Neoplasm Metastasis (Metastasis)
01/2019 - 01/2015
2Ovarian Neoplasms (Ovarian Cancer)
03/2021 - 01/2021
2Squamous Cell Carcinoma of Head and Neck
10/2020 - 06/2019
2Hypoxia (Hypoxemia)
10/2020 - 06/2014
2Adenocarcinoma
10/2019 - 09/2018
2Alveolar Rhabdomyosarcoma
04/2019 - 09/2018
2Head and Neck Neoplasms (Head and Neck Cancer)
10/2017 - 08/2017
2Carcinogenesis
05/2017 - 01/2014
2Pain (Aches)
03/2016 - 01/2015
1Fibrosis (Cirrhosis)
05/2021
1Vascular System Injuries
05/2021
1Disease Progression
05/2021
1Autoimmune Diseases (Autoimmune Disease)
05/2021
1Endometrioid Carcinoma
04/2021
1Diabetic Cardiomyopathies
03/2021
1Muscular Diseases (Myopathy)
03/2021
1Cardiomyopathies (Cardiomyopathy)
03/2021
1Ovarian Epithelial Carcinoma
01/2021

Drug/Important Bio-Agent (IBA)

9Hormones (Hormone)IBA
01/2021 - 08/2010
9DNA (Deoxyribonucleic Acid)IBA
01/2017 - 11/2010
8Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 12/2005
7Proteins (Proteins, Gene)FDA Link
02/2022 - 08/2006
7Pharmaceutical PreparationsIBA
02/2022 - 03/2012
6U 0126 (UO 126)IBA
10/2020 - 12/2005
6AndrogensIBA
09/2016 - 12/2011
5Phosphotransferases (Kinase)IBA
02/2022 - 01/2011
5Androgen Receptors (Androgen Receptor)IBA
01/2021 - 08/2010
5Cyclin D1IBA
12/2017 - 12/2015
4Histone Deacetylase InhibitorsIBA
10/2021 - 03/2012
4Reactive Oxygen Species (Oxygen Radicals)IBA
05/2021 - 10/2013
4Temozolomide (Temodar)FDA LinkGeneric
09/2019 - 01/2017
4MethyltransferasesIBA
09/2019 - 11/2010
4Biological ProductsIBA
05/2019 - 11/2010
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2020 - 03/2009
3EphrinsIBA
01/2020 - 10/2017
3Docetaxel (Taxotere)FDA Link
10/2019 - 08/2011
3Mechanistic Target of Rapamycin Complex 2IBA
10/2019 - 08/2011
3Mechanistic Target of Rapamycin Complex 1IBA
10/2019 - 08/2011
3belinostatIBA
10/2019 - 03/2012
3Histone Deacetylases (Histone Deacetylase)IBA
01/2019 - 01/2017
3SurvivinIBA
01/2016 - 06/2014
2PBI-05204IBA
01/2022 - 01/2020
2Sildenafil Citrate (Viagra)FDA Link
05/2021 - 03/2021
2Phosphodiesterase 5 InhibitorsIBA
05/2021 - 03/2021
2OTX015IBA
03/2021 - 01/2020
2Caveolin 1IBA
01/2021 - 01/2019
2olaparibIBA
01/2021 - 01/2017
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2020 - 02/2020
2ErythropoietinFDA Link
01/2020 - 10/2017
2AntioxidantsIBA
01/2020 - 04/2019
2thiamine triphosphorate (TTP)IBA
10/2019 - 06/2014
2Therapeutic UsesIBA
10/2019 - 12/2015
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019 - 01/2017
2givinostat hydrochlorideIBA
01/2019 - 01/2019
2givinostatIBA
01/2019 - 01/2019
2Azacitidine (5 Azacytidine)FDA Link
07/2016 - 03/2013
2selinexorIBA
01/2016 - 12/2015
2palomid 529IBA
06/2014 - 08/2011
2lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
06/2014 - 01/2011
2bicalutamide (Casodex)FDA LinkGeneric
12/2011 - 08/2010
1naxagolideIBA
06/2022
1Focal Adhesion Protein-Tyrosine KinasesIBA
02/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2022
1IntegrinsIBA
02/2022
1Peptides (Polypeptides)IBA
01/2022
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2022
1Cell-Penetrating PeptidesIBA
01/2022
1oleandrinIBA
01/2022
1Cardiac GlycosidesIBA
01/2022
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2022
1sulforaphaneIBA
10/2021
1entinostat (MS 275)IBA
10/2021
1Biomarkers (Surrogate Marker)IBA
05/2021
1LigandsIBA
03/2021
1CXC ChemokinesIBA
03/2021
1Aromatase (CYP19)IBA
01/2021
1SteroidsIBA
01/2021
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2021
1Tadalafil (Cialis)FDA Link
01/2021
1CateninsIBA
01/2021
1romidepsin (FK228)FDA Link
01/2021
1Cyclin AIBA
01/2021
1Dopamine Receptors (Dopamine Receptor)IBA
11/2020

Therapy/Procedure

24Radiotherapy
01/2022 - 01/2011
17Therapeutics
02/2022 - 08/2006
9Drug Therapy (Chemotherapy)
01/2021 - 11/2010
5Castration
12/2017 - 10/2011
3Adjuvant Radiotherapy
12/2019 - 11/2016
2Brachytherapy
04/2020 - 02/2020
2Aftercare (After-Treatment)
01/2017 - 01/2015
2Cryosurgery
03/2016 - 01/2015